Order Article Reprints

Tsai H-P, Hou P-H, Mao F-C, Chang C-C, Yang W-C, Wu C-F, Liao H-J, Lin T-C, Chou L-S, Hsiao L-W, et al. Risperidone Exacerbates Glucose Intolerance, Nonalcoholic Fatty Liver Disease, and Renal Impairment in Obese Mice. International Journal of Molecular Sciences. 2021; 22(1):409. https://doi.org/10.3390/ijms22010409

Tsai, Hsiao-Pei, Po-Hsun Hou, Frank-Chiahung Mao, Chia-Chia Chang, Wei-Cheng Yang, Ching-Feng Wu, Huei-Jyuan Liao, Tzu-Chun Lin, Lan-Szu Chou, Li-Wei Hsiao, and et al. 2021. "Risperidone Exacerbates Glucose Intolerance, Nonalcoholic Fatty Liver Disease, and Renal Impairment in Obese Mice" International Journal of Molecular Sciences 22, no. 1: 409. https://doi.org/10.3390/ijms22010409

Tsai, H.-P., Hou, P.-H., Mao, F.-C., Chang, C.-C., Yang, W.-C., Wu, C.-F., Liao, H.-J., Lin, T.-C., Chou, L.-S., Hsiao, L.-W., & Chang, G.-R. (2021). Risperidone Exacerbates Glucose Intolerance, Nonalcoholic Fatty Liver Disease, and Renal Impairment in Obese Mice. International Journal of Molecular Sciences, 22(1), 409. https://doi.org/10.3390/ijms22010409